Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Venkata S. Akshintala, M.D.
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Asian Institute of Gastroenterology
Hyderabad, Andhra Pradesh, India
Recruiting - Apollo Multispecialty Hospitals,
Kolkata, West Bengal, India
Not, yet, recruiting - Post Graduate Institute of Medical Education and Research
Chandigarh, India
Not, yet, recruiting
- Singapore General Hospital
Singapore, Singapore
Not, yet, recruiting
- Johns Hopkins Hospital
Baltimore, Maryland, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jan 2023
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 9 Dec 2025
- Registered enrollment
- 4,874
- Registry id
- NCT05252754
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.